Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Multiple Sclerosis and Related Disorders
|
December 22, 2022
Oral disease modifying therapies - A game changer for treatment decision in untreated patients with RRMS and CIS? - A swiss single center cross-sectional study
Sebastian Finkener, Lutz Achtnichts, Michaela Cervenakova, et al.
Clinical Parkinsonism & Related Disorders
|
March 29, 2022
Recognizing myorhythmia 4 months after stroke - A teaching video
Sebastian Finkener, Tobias Piroth, Magdalena Högg, et al.
BMC Infectious Diseases
|
September 4, 2024
Transfusion-related acute lung injury (TRALI) following intravenous immunoglobulin infusion in a rituximab immunosuppressed patient with long-shedding SARS-CoV-2
Ganna Degtiarova, Anna Conen, Alexander Klarer, et al.
Advances in Therapy
|
March 10, 2026
The Treatment of Antibody-Mediated Encephalitis: Current, Future Therapies, Unmet Need and Patient Management
Smaila Mulic-Al Bunni, Markus Gschwind, Sebastian Finkener, et al.
Clinical Chemistry and Laboratory Medicine
|
December 26, 2025
Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls
Eline A J Willemse, Sofia Sandgren, Pascal Benkert, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 23, 2026
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond
Johanna Oechtering, Sabine Anna Schaedelin, Aleksandra Maleska Maceski, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
February 28, 2025
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort
Giulio Disanto, Sabine Schaedelin, Johanna Oechtering, et al.
Neurology. Clinical Practice
|
July 7, 2025
Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis Cohort
Maximilian Einsiedler, Chiara Zecca, Lisa Hofer, et al.
Journal of Neurology
|
July 2, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort
Alessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 29, 2025
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study
Özgür Yaldizli, Pascal Benkert, Lutz Achtnichts, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Multiple Sclerosis and Related Disorders
|
December 22, 2022
Oral disease modifying therapies - A game changer for treatment decision in untreated patients with RRMS and CIS? - A swiss single center cross-sectional study
Sebastian Finkener, Lutz Achtnichts, Michaela Cervenakova, et al.
Clinical Parkinsonism & Related Disorders
|
March 29, 2022
Recognizing myorhythmia 4 months after stroke - A teaching video
Sebastian Finkener, Tobias Piroth, Magdalena Högg, et al.
BMC Infectious Diseases
|
September 4, 2024
Transfusion-related acute lung injury (TRALI) following intravenous immunoglobulin infusion in a rituximab immunosuppressed patient with long-shedding SARS-CoV-2
Ganna Degtiarova, Anna Conen, Alexander Klarer, et al.
Advances in Therapy
|
March 10, 2026
The Treatment of Antibody-Mediated Encephalitis: Current, Future Therapies, Unmet Need and Patient Management
Smaila Mulic-Al Bunni, Markus Gschwind, Sebastian Finkener, et al.
Clinical Chemistry and Laboratory Medicine
|
December 26, 2025
Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls
Eline A J Willemse, Sofia Sandgren, Pascal Benkert, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 23, 2026
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond
Johanna Oechtering, Sabine Anna Schaedelin, Aleksandra Maleska Maceski, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
February 28, 2025
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort
Giulio Disanto, Sabine Schaedelin, Johanna Oechtering, et al.
Neurology. Clinical Practice
|
July 7, 2025
Treatment Strategies and Disease Activity During Pregnancy and Postpartum: Real-World Data From the Swiss Multiple Sclerosis Cohort
Maximilian Einsiedler, Chiara Zecca, Lisa Hofer, et al.
Journal of Neurology
|
July 2, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort
Alessandro Cagol, Sabine Schaedelin, Mario Ocampo-Pineda, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 29, 2025
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study
Özgür Yaldizli, Pascal Benkert, Lutz Achtnichts, et al.
Page
of 2